Shareholding disclosure

Cytos Biotechnology AG

Declared position

1.95%

Threshold

Crossed upwards

Timeline

Published

14.05.2015

Transaction

11.05.2015

Voting rights breakdown

Voting rights acquired1.95%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAF5C00077

Beneficial owner

Cytos Biotechnology AG

Declared address

Cytos Biotechnology AG, 8952 Schlieren

Decreased percentage ownership of treasury shares due to capital increase caused by the mandatory conversion of the convertible bonds.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Cytos Biotechnology AG

Kuros Biosciences AG14.05.2015TAF5C00077

Disclosure summary

Cytos Biotechnology AG disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 14.05.2015, at 1.95% of voting rights. Notice category: Single shareholder.

Disclosed position

1.95%

Voting rights acquired

Voting rights acquired1.95%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Cytos Biotechnology AG disclosed a holding in Kuros Biosciences AG, published on 14.05.2015.

Publication date14.05.2015

Transaction date11.05.2015

Issuing companyKuros Biosciences AG

Beneficial ownerCytos Biotechnology AG

Declared addressCytos Biotechnology AG, 8952 Schlieren

CategorySingle shareholder

Voting rights acquired1.95%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAF5C00077

Commercial register

CHE-104.785.642

Registered

Zefix record

Conditions

Decreased percentage ownership of treasury shares due to capital increase caused by the mandatory conversion of the convertible bonds.

Source: SIX Exchange Regulation · Publication date: 14.05.2015

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open